Fact sheet: BB Medtech

Fund information

Fund name
BB Medtech B EUR
Fund company manager
Bellevue Asset Management
Fund type
SIB
Fund manager(s)
Stefan Blum
since 30/09/2009
Marcel Fritsch
since 30/09/2009
Fund objective
The Fund’s investment objective is to generate attractive and competitive capital growth in the long term. It is therefore particularly suited to investors with an investment horizon of at least 5 years who want to selectively diversify their portfolio with investments in the medtech sector and who are willing to accept the equity risk typical of this sector.
Benchmark
MSCI Healthcare Equip. & Supp
Investment style
None
Investment method
Shares

Quick stats

1 Year return

18.19 %

1 Year rank in sector

4/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 234.8 m

FE Risk score

134

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    83%
  • Denmark
    4.3%
  • Money Market
    4.3%
  • Netherlands
    3.7%
  • Japan
    2.1%
  • Health Care
    80.8%
  • Others
    11.9%
  • Biotechnology/Medical
    6.1%
  • Money Market
    1.2%
  • US Equities
    86.1%
  • Danish Equities
    4.1%
  • Dutch Equities
    3.2%
  • International Equities
    3.2%
  • Japanese Equities
    2.2%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund7.98 %18.03 %18.19 %49.53 %129.87 %
Sector4.43 %7.27 %9.8 %3.06 %79.06 %
Rank within sector3 / 312 / 304 / 303 / 292 / 21
Quartile th1 st1 st1 st1 st1 st

Calendar performance

YTD-20182017201620152014
Fund20.77 %13.87 %6.5 %10.88 %35.42 %
Sector6.7 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector1 / 3019 / 293 / 298 / 257 / 22
Quartile th1 st3 rd1 st2 nd2 nd

Risk statistics

Alpha11.84
Beta0.7
Sharpe0.59
Volatility13.39
Tracking error9.6
Information ratio1.24
R-Squared0.63

Price movement

52 week high433.99
52 week low338.96
Current bid price0
Current offer price0
Current mid price433.99

Holdings by region

  • 83% USA
  • 4.3% Denmark
  • 4.3% Money Market
  • 3.7% Netherlands
  • 2.1% Japan
  • 1.7% Others
  • 0.9% France

Holdings by sector

  • 80.8% Health Care
  • 11.9% Others
  • 6.1% Biotechnology/Medical
  • 1.2% Money Market

Holdings by asset type

  • 86.1% US Equities
  • 4.1% Danish Equities
  • 3.2% Dutch Equities
  • 3.2% International Equities
  • 2.2% Japanese Equities
  • 1.2% Money Market

Individual holdings

  • 9.2% MEDTRONIC PLC
  • 8.6% ABBOTT LABORATORIES
  • 5.6% BOSTON SCIENTIFIC CORP
  • 5.4% DANAHER CORP
  • 5.2% STRYKER CORP
  • 4.2% BECTON DICKINSON & CO
  • 4% EDWARDS LIFESCIENCES CORP
  • 3.9% INTUITIVE SURGICAL INC
  • 3.7% KONINKLIJKE PHILIPS NV
  • 3.6% BAXTER INTL